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Here we report the first assessment of the expression
and modulation of an invertebrate 1 subunit homolog
of mammalian presynaptic Cav2 calcium channels (N-
type and P/Q-type) in mammalian cells. Our data show
that molluscan channel (LCav2a) isolated from Lymnaea
stagnalis is effectively membrane-targeted and electro-
physiologically recordable in tsA-201 cells only when the
first 44 amino acids of LCav2a are substituted for the
corresponding region of rat Cav2.1. When coexpressed
with rat accessory subunits, the biophysical properties
of LCav2a-5rbA resemble those of mammalian N-type
calcium channels with respect to activation and inacti-
vation, lack of pronounced calcium dependent inactiva-
tion, preferential permeation of barium ions, and cad-
mium block. Consistent with reports of native Lymnaea
calcium currents, the LCav2a-5rbA channel is insensi-
tive to micromolar concentrations of -conotoxin GVIA
and is not affected by nifedipine, thus confirming that it
is not of the L-type. Interestingly, the LCav2a-5rbA
channel is almost completely and irreversibly inhibited
by guanosine 5-3-O-(thio)triphosphate but not regu-
lated by syntaxin1, suggesting that invertebrate presyn-
aptic calcium channels are differently modulated from
their vertebrate counterparts.
Calcium entry through voltage-gated calcium channels me-
diates a plethora of cytoplasmic responses, including the acti-
vation of enzymes, the initiation of gene transcription, neurite
outgrowth and neurotransmitter release (1–3). Based on their
functional and pharmacological profiles, voltage-gated calcium
channels have been classified into T-, N-, L-, P/Q-, and R-types,
each with unique physiological roles (1). With the exception of
the T-types, voltage-gated calcium channels are heteromultim-
ers comprised of a principal 1 subunit that defines the calcium
channel subtype plus the accessory  (4), 2- (5), and possibly
 (6) subunits which modulate the functional and pharmaco-
logical properties of the 1 subunit (1, 7). Molecular cloning has
identified 4 genes, each encoding  and 2- subunits, 8 genes
encoding  subunits, and 10 genes representing different types
of calcium channel 1 subunits (1). The various 1 subunits fall
into three distinct classes. The Cav1 class encodes L-type cal-
cium channels, Cav2.1, Cav2.2, and Cav2.3, respectively, repre-
sent P/Q-type, N-type, and R-type channels, and Cav3 encodes
the family of T-type calcium channels (1).
Cav2.1 (P/Q-type) and Cav2.2 (N-type) channels are densely
localized at presynaptic zones of vertebrate neurons (8–10)
where they are physically coupled to proteins of the synaptic
vesicle release proteins such as syntaxin1, SNAP25, and syn-
aptotagmin (1, 2, 7, 11). This possibly serves to optimize the
efficiency of synaptic transmission and as a negative feedback
mechanism allowing the regulation of calcium channel activity
during various steps of exocytosis (7, 12). Mammalian N-type
and P/Q-type calcium channels are differentially inhibited
upon activation of G protein-coupled receptors (7, 13–15). This
effect is mediated by G protein  subunits and may serve to
fine-tune synaptic activity.
Invertebrate species do not appear to contain the same struc-
tural diversity of vertebrate calcium channel genes in their
genomes and, with one possible exception (16), possess only
single homologs of the three major calcium channel families,
Cav1, Cav2, and Cav3 (12, 17). Invertebrate Cav2 representa-
tives are considered functional as well as structural correlates
of both mammalian N- (Cav2.2) and P/Q-type (Cav2.1) calcium
channels (12, 17). Cav2 homologs from Drosophila (DmCa1A/
cac) (18, 19), Caenorhabditis elegans (unc-2) (20), and more
recently, the freshwater mollusk Lymnaea stagnalis (LCav2a)
(21), are required for invertebrate synaptic transmission, rem-
iniscent of the roles of N- and P/Q-type channels in mammalian
synapses (3, 22). The invertebrate Cav2 calcium channel 1
subunits, unlike mammalian N-type and P/Q-type calcium
channels, do not display an elongated domain II-III linker
region, which in mammalian synaptic channels characteristi-
cally contain interaction sites for syntaxin, SNAP-25, and syn-
aptotagmin (19, 21). However, although full-length sequences
of invertebrate presynaptic calcium channels have been in the
public domain for years, there has not been a report describing
the functional expression of any of the cloned invertebrate Cav2
synaptic calcium channels. An exception to this is a single
report of expression of a squid Cav2 homolog in Xenopus oocytes
(23), a system known to endogenously express calcium chan-
nels as well as low levels of synaptic proteins. This has pre-
cluded a detailed functional analysis of these channels and has
been an obstacle to taking full advantage of invertebrate syn-
aptic preparations to address fundamental aspects of synaptic
transmission at the molecular level.
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Here we report the expression and characterization of a L.
stagnalis Cav2 calcium channel 1 subunit homolog (LCav2a).
We show that LCav2a channels are ineffectively targeted to the
plasma membrane but that this can be overcome by the re-
placement of a short stretch of amino acids at the N-terminal
region of LCav2a (44 amino acids) with its counterpart from rat
Cav2.1. When coexpressed with rat 1b and 2-, the functional
properties of the modified LCav2a-5rbA calcium channel re-
semble in many ways those of mammalian N-type calcium
channels showing similar activation and inactivation behavior,
preferential permeation of barium over calcium, a lack of pro-
nounced calcium-dependent inactivation, and complete block
by cadmium ions. Consistent with what has been reported for
native Lymnaea calcium currents in neurons (24, 25), the
LCav2a-5rbA channel is insensitive to micromolar concentra-
tions of -conotoxin GVIA and does not have characteristics of
L-type channels with regard to nifedipine sensitivity. As ex-
pected from the lack of an identifiable syntaxin binding site
(21), the coexpression of the channel with Lymnaea syntaxin1
did not affect channel function. Interestingly, the channel was
irreversibly inhibited in the presence of GTPS1 but not func-
tionally affected by syntaxin1, suggesting that invertebrate
calcium channels may display distinct regulation from their
vertebrate counterparts.
EXPERIMENTAL PROCEDURES
Preparation of Full-length LCav2a and Lsytx1A cDNAs for Expres-
sion—Full-length cDNA homologs of Lymnaea Cav2 (LCav2a, Gen-
BankTM accession number AF484082) and syntaxin1 (Lsytx1, Gen-
BankTM accession number AF484088) were constructed from fresh
Lymnaea brain cDNA by PCR using proofreading Turbo Pfu (Strat-
agene) polymerase and primers flanking the identified start and stop
codons of the open reading frame (molecular cloning of LCav2a and
Lsytx1, described in Spafford et al. (21)). The 2141- and 290-amino acid
coding region of LCav2a and Lsytx1 was inserted using primer-incorpo-
rated 5 NotI and 3 XhoI restriction sites into the polylinker of the
mammalian expression vector PMT2SX. A consensus Kozak sequence
was constructed in the 5 NotI site immediately upstream from the start
(ATG) codon, CGGCCGCCACC(ATG). When functional expression of
LCav2a failed, the construct LCav2a-5rbA was designed. For LCav2a-
5rbA, a silent MluI restriction site was created at arginine, position 45,
and the 5 end of rat Cav2.1 homologue (gi:203110) was inserted by
PCR. This included the region of the native Kozak sequence (7 bp of the
5-untranslated sequence) followed by the coding region of the first 77
amino acids at the N terminus of LCav2a, from the 5 NotI site in the
polylinker to the downstream MluI site.
Sequence Comparisons—Lymnaea genes and rat homologs were
aligned using a progressive pairwise, multiple alignment in PILEUP
(UNIX-based, GCG Wisconsin Package 2002, Accelrys, Madison, WI).
Aligned rat genes included Cav2.1 (P/Q type) (GI:1705706), Cav2.2
(N-type) (GI:25453410), syntaxin1A (GI:417842), and syntaxin1B
(GI:631888).
Preparation of LCav2 Polyclonal Antibody—The antigen to make the
calcium channel polyclonal antibody was derived from a 15-mer pep-
tide, KAEDNENDSEQNDND (Henk Hilkman, Netherlands Cancer In-
stitute, Amsterdam), corresponding to amino acids 418–432 of LCav2a
cytoplasmic I-II linker. The purity of the peptide was confirmed by
matrix-assisted laser desorption ionization mass spectrometry and an-
alytical high performance liquid chromatography. Rabbits were immu-
nized for a 4-week period with adjuvants and antigen conjugated to the
carrier protein KLH (Washington Biotechnology Inc., Baltimore, MD).
IgG rabbit antiserum was tested for immunoreactivity with the antigen
by spot blot.
Transient Transfection of Mammalian Cells—Human embryonic kid-
ney tsA-201 cells were grown and transfected using standard calcium
phosphate protocol (26). cDNAs transfected included a cDNA construct
encoding for green fluorescent protein (Clontech), calcium channel sub-
units rat 2-1 and rat 1b, and either LCav2a or LCav2a-5rbA or rat
Cav2.2, plus when stated, Lsytx1A, rat syntaxin1A, or C-terminal frag-
ment of the -adrenergic receptor kinase (-ARKct). Cells slated for
immunohistochemistry were left to incubate at 37 °C on poly-L-lysine-
coated dishes, whereas those slated for electrophysiological experi-
ments were incubated at 28 °C for 2–4 days before analysis.
LCav2 Immunostaining in Mammalian Cells—Mock-transfected tsA-
201 cells or tsA-201 cells transfected with rat 2-1, rat 1b, and either
LCav2a or LCav2a-5rbA were incubated at 37 °C for 4 days, fixed with
1% paraformaldehyde for 12 h at 4 °C, then permeabilized in 1% Non-
idet-P40 (octylphenoxypolyethoxyethanol polyethyleneglycol-p-isooctyl-
phenyl ether) for 1 h at room temperature. Afterward, cells were
washed in TBS-BSA-Triton blocking agent (50 mM Tris, 150 mM NaCl,
1 g/liter bovine serum albumin; Sigma-Aldrich, A9647), 0.5% Triton-
X100, pH 7.4, and then incubated with 1:1000 dilution, LCav2 anti-
rabbit polyclonal antibody in TBS-BSA-Triton overnight at 4 °C. The
next day cells were exposed to 10 washes in TBS-BSA-Triton and
treated with a 1:500 dilution of Alexa Fluor 568 goat anti-rabbit IgG
(Molecular Probes, Inc., Eugene OR) in TBS-BSA-Triton overnight at
4 °C. The next day, cells were washed 10 in TBS (50 mM Tris, 150 mM
NaCl, pH 7.4), wet-dried, and mounted in fluorescence anti-fading
media (ProLong AntiFade, Molecular Probes). Images were visualized
and analyzed on an Olympus confocal microscope.
Immunoblot Analysis of LCav2 and Lsytx1 Protein Expression in
tsA-201 Cells—Transiently transfected or untransfected tsA-201 cells
incubated for 4 days at 37 °C were harvested for Western blot analysis
using a standard procedure (26). Proteins were detected with primary
antibodies at 1:2000 dilution, raised in rabbits against LCav2a or Lsytx1
(ANR-002, Alomone Labs, Jerusalem, Israel). Color detection of gel
blots were processed using previously described methods (21).
Functional Assessment and Analysis of LCav2 cDNA Expression—
Calcium channel activity in transiently transfected tsA-201 cells was
characterized via whole cell patch clamp using an Axopatch 200B
amplifier (Axon Instruments, Union City, CA), pCLAMP 9.0 software,
and previously described recording procedures and solutions (26). Data
analysis was carried out using Clampfit (pClamp 9, Axon Instruments)
and SigmaPlot 2000 (Jandel Scientific, SPSS Science, Chicago, IL.).
Steady state inactivation curves were fit with standard Boltzmann
relations I  1/(1  exp(V  Vh/S)), where I is the normalized peak
current amplitude, V is the holding potential, Vh is the half-inactivation
potential, and S is a slope factor. Whole cell current voltage relations
were fitted with the equation I  G(V  Erev)/(1  exp(Va  V)/S), where
G is the maximum slope conductance, I is the peak current amplitude,
V is the test potential, Erev is the reversal potential, Va is the half-
activation potential, and S is a slope factor inversely proportional the
effective gating charge. Time constants for inactivation, , were deter-
mined from monoexponential fits to the raw data (Fig. 3A). Error bars
reflect S.E., and numbers in parentheses reflect numbers of experi-
ments. Statistical analysis was carried out using Sigmastat (Jandel
Scientific). Differences between mean values from each experimental
group were tested using paired and unpaired Student’s t tests and were
considered significant if p  0.05.
RESULTS AND DISCUSSION
The N Terminus Region of Cav2 Calcium Channels Regulates
Membrane Trafficking—We have recently reported the effects
of RNA-mediated interference knockdown of a Cav2 calcium
channel homolog on Lymnaea synaptic transmission (21). Our
data revealed that synaptic transmission in identified Lym-
naea neurons was dependent on a Cav2 calcium channel hom-
olog (LCav2a) that is capable of associating with the scaffolding
proteins Mint-1 and CASK but which curiously lacks the syn-
aptic protein interaction site common to mammalian presyn-
aptic calcium channels (21) (see Fig. 1, A and B). To function-
ally characterize the LCav2a channels, we generated a
full-length cDNA inserted in a mammalian expression vector
and coexpressed the channel with rat 1b and 2-1 accessory
subunits and an enhanced green fluorescent protein expression
marker in tsA-201 cells. Repeated attempts (n  24) to record
current activity via whole cell patch clamp recordings failed,
consistent with the lack of any reports of expression of synaptic
invertebrate calcium channels in cell lines. To determine
whether our inability to record from LCav2a calcium channels
was due to inefficient protein synthesis or membrane targeting,
we generated an antibody based upon a 15-mer peptide se-
quence of LCav2a in a region of low similarity among calcium
channels and, thus, a low probability of interaction with other
1 The abbreviations used are: GTPS, guanosine 5-3-O-(thio)triphos-
phate; BSA, bovine serum albumin.















proteins (see Fig. 1A). Using this antibody, we determined the
expression pattern of LCav2a in transfected tsA-201 cells via
confocal fluorescence microscopy. The antibody produced al-
most no background staining in mock-transfected cells (Fig.
2A). When cells were transfected with LCav2a together with
appropriate ancillary subunits (Fig. 2B), staining could be ob-
served in cytoplasmic compartments, but much less membrane
staining was apparent, suggesting that LCav2a protein is syn-
thesized but not efficiently targeted to the plasma membrane,
thus accounting for the lack of barium currents in our electro-
physiological analysis.
We then attempted a strategy used previously to obtain
expression of a mammalian Cav2.2 calcium channel variant in
Xenopus oocytes (27–29) by replacing part of the N-terminal
region of the LCav2a channel (44 amino acids) with the corre-
sponding sequence from rat Cav2.1 (creating LCav2a-5rbA). As
shown in Fig. 2C, LCav2a-5rbA is detected in the plasma
membrane as rings of fluorescence of differing intensities
around the cell edges, apparent in approximately one-third of
all transfected cells, similar to the fraction of green fluorescent
protein-positive cells in typical transfections. Single bands of
predicted size (240 kDa) for LCav2a were detected in an
immunoblot of LCav2a and LCav2a-5rbA-transfected tsA-201
cells but not in mock-transfected cells (Fig. 2D). Together with
the relatively low abundance of membrane staining and ab-
sence of observed barium currents in LCav2a-transfected cells,
this indicates that the native N terminus of LCav2a either
directly antagonizes plasma membrane trafficking in mamma-
lian cells or that it might be missing an N-terminal domain
required for efficient trafficking or stabilization of channels in
mammalian cell membranes (see Fig. 2E for sequence align-
ment of the rat Cav2.2 and LCav2a N-terminal regions). It is
interesting to note that among rat Cav2 channels, there is a
common, almost identical 28-amino acid N-terminal sequence
just upstream of where LCav2a differs with rat channels (see
the boxed amino-acids, Fig. 2E), raising the possibility that this
motif may perhaps be involved in membrane targeting. Further
construction of chimeras will be needed to substantiate this
possibility.
The Biophysical Properties of LCav2a-5rbA Are Similar to
Those of Mammalian N-type Channels—When analyzed elec-
trophysiologically, the LCav2a-5rbA channel construct re-
sulted in robust barium currents in 46 of 82 green fluorescent
protein-positive cells when transiently expressed in tsA-201
cells. This clearly contrasts with the lack of detectable expres-
sion of the wild type LCav2a channel. We therefore carried out
a detailed analysis of biophysical properties of the LCav2a-
5rbA calcium channel. A shown in Fig. 3A, the LCav2a-5rbA
channel supports barium currents with moderate inactivation
kinetics. As seen from the ensemble current-voltage relations
(Fig. 3B), currents first activate at about 20 mV and peak
near 20 mV. The half-activation potential determined from
the fit of the IV curve was 8.5 mV, consistent with LCav2a-
5rbA acting as a high voltage-activated calcium channel. A
similar value was obtained from fits to individual IV relations
(10.8  1.9 mV, n  26). The peak of the IV curve of LCav2a-
5rbA is shifted about 20 mV positive to the human Cav2.2
(N-type) calcium channel (30) and about 10 mV positive to the
FIG. 1. A, schematic representation of
the 1 subunit of LCav2a calcium channel
with highlighted regions of significance
described in the text (indicated by bold
segments). Note that the II-III linker of
LCav2a has a dramatically shortened in-
tracellular loop compared with rat Cav2
homologs. B, sequence alignment of the
shorter II-III linker region of LCav2a with
the equivalent region in rat Cav2.2, which
is longer and contains a synaptic protein
interaction (synprint) site common to ver-
tebrate presynaptic calcium channels
(dotted line above sequence). Indicated
are arrows delimiting the homologous re-
gion in rat Cav2.2 (1B) that is absent in a
human 1B 	1 and 	2 splice variants. 1B
	2 eliminates most of the synprint site,
and as a consequence, there is a loss of
syntaxin1A binding capacity in the hu-
man II-III linker (46). (ŒA) and (ŒB) refer
to small insertions of 4 and 13 amino ac-
ids, respectively, found within C-termi-
nally truncated, b variant of LCav2.















rat Cav2.2 isoform (31) under similar experimental conditions.
Steady state inactivation of the LCav2a-5rbA channels were
examined using 5-s prepulses to various holding potentials
before a 20-mV test depolarization. The ensemble of the
steady state inactivation curves is well described by a Boltz-
mann relation (Fig. 3C). The half-inactivation potential from
the ensemble fit (39.9 mV) and from fits to individual steady
state inactivation curves (39.6  6.4 mV, n  14) is about 10
mV more positive than that of the human Cav2.2 calcium
channel (30) and about 5 mV more depolarized than that seen
with rat Cav2.2 (26, 32) under these experimental conditions.
As seen with mammalian calcium channels, the voltage de-
pendence of the time constant of inactivation slightly decreases
at more depolarized potentials (Fig. 3D).
Fig. 4A depicts current records obtained from the same cell
in 20 mM external barium and 20 mM external calcium. As
evident from these current recordings and from the current
voltage relations in Fig. 4B, replacement of barium with cal-
cium resulted in a dramatic reduction in peak current ampli-
tude as seen with many other types of vertebrate mammalian
high voltage-activated calcium channels. In six such paired
experiments, the maximum slope conductance underwent a
statistically significant reduction (from 10.5  1.8 nanosiemens
to 3.95  0.56 nanosiemens, n  6, p  0.05) when calcium
replaced barium as the external charge carrier (see the inset to
Fig. 4B). This effect may be due to a reduction in single channel
conductance, an effect on maximum open probability, or a
combination thereof and is seen with most types of mammalian
high voltage-activated calcium channels with the exception of
Cav2.3 (33). These data are consistent with the observation
that the selectivity filter region in the four transmembrane
domains of Cav2.1 and Cav2.2 calcium channels is conserved in
LCav2a (see Fig. 4C). In addition, the half-activation potential
in this set of experiments shifted from 8.1  2.5 to 26.58  1.8
mV (n  6, p  0.05), as reported for a number of voltage-gated
calcium channels (see Refs. 33 and 34). It is interesting to note
that half-activation potential shifts of this magnitude are more
typical to L-type calcium channels, with N-type and P/Q-type
channels showing a smaller (10 mV) effect (33).
We also examined the time course of inactivation in both
barium and calcium. As shown in Fig. 4C, when the current
records of Fig. 4A were superimposed to overlap at peak, a
small degree of kinetic speeding could be observed in calcium,
perhaps indicative of a small degree of calcium-sensitive inac-
tivation. Examination of this effect at a number of different test
potentials shows that calcium significantly speeds the rate of
inactivation at more depolarized voltages (Fig. 4D). This small
degree of speeding is comparable with that reported for rat
P/Q-type calcium channels but much less pronounced than the
calcium-dependent inactivation of L-type calcium channels. It
is, however, important to note that the calcium-induced
20-mV shift in half-activation potential could potentially re-
FIG. 2. A, B, and C, immunostained
tsA-201 cells with LCav2 antibody super-
imposed on bright field images. tsA-201
cells were either mock-transfected (A) or
transfected with LCav2a and rat 1b  rat
2-1 (B) or LCav2a-5rbA and rat 1b 
rat 2-1 (C). Note that LCav2a and
LCav2a-5rbA dramatically differ in their
membrane-delimited staining. D, West-
ern blot of tsA-201 protein homogenate
either mock-transfected or transfected
with LCav2a  rat 1b  rat 2-1, or
LCav2a-5rbA  rat 1b  rat 2-1 and
probed with LCav2 antibody. Note that
the antibody recognizes a single band of
the expected 240-kDa size in lanes con-
taining LCav2a and LCav2a-5rbA but not
in the lane containing protein homoge-
nate of mock-transfected cells. E, se-
quence alignment of the N-terminal re-
gions of rat Cav2.1, rat Cav2.2, and
LCav2a calcium channels. Note the large
degree of sequence divergence in an align-
ment of the first 44 amino acids of
LCav2a. The arrow indicates the location
of the MluI site used to swap N termini of
Lymnaea for rat Cav2.1 (dotted line above
the sequence) to create the chimeric
LCav2a-5rbA channel. Boxed amino-ac-
ids represent a highly conserved sequence
in vertebrate Cav2 channels.















sult in a similar shift in the voltage dependence of the time
constant for voltage-dependent inactivation, thus attributing
the observed effects purely to voltage-dependent rather than
calcium-dependent inactivation (i.e. compare the inactivation
time constants in barium and calcium at 40 and 60 mV,
respectively). Taken together, our data thus indicate that
LCav2a-5rbA calcium channels undergo only little if any
calcium-dependent inactivation.
LCav2a-5rbA Channels Are -Conotoxin GVIA-resistant—It
has been shown previously that native Lymnaea neuronal
whole cell calcium currents are insensitive to classical blockers
such as -conotoxin GVIA and nifedipine (24, 25). Indeed, to
date no selective blocker of these native currents has been
identified. As shown in Fig. 5A, the LCav2a-5rbA channel
shows the predicted lack of nifedipine and -conotoxin GVIA
block. At concentrations (i.e. 3 M GVIA and 5 M nifedipine) at
which mammalian N-type and L-type channels would, respec-
tively, be completely blocked (35, 36), the LCav2a-5rbA chan-
nel showed only about a 10% reduction in peak current ampli-
tude in response to -conotoxin GVIA and no detectable
inhibition by nifedipine. In contrast, application of 100 M
cadmium completely abolished current activity within 10 s of
application, as expected from a high voltage-activated calcium
channel. The lack of conotoxin inhibition is interesting given
the relatively high degree of sequence homology within the
putative -conotoxin GVIA binding region of the Cav2.2 cal-
cium channel domain III S5-S6 region (Fig. 5B, see Refs. 27 and
36). By contrast, the inhibition by cadmium ions is consistent
with the sequence conservation of the narrow region of the pore
(Fig. 4E, see Refs. 37 and 38).
LCav2a-5rbA Is Uniquely Regulated by G Proteins—Both
rat N-type and P/Q-type calcium channels are inhibited by
direct interactions with G protein  subunits (see Refs. 39–
41). A hallmark of G protein inhibition of these channels is that
it can be relieved after the application of a strong depolarizing
prepulse (see 42, 43). Under control conditions, the application
of such a prepulse resulted in a slight decrease in peak current
amplitude by 13  2.9% (n  16), presumably due to a small
degree of inactivation occurring during the prepulse and indi-
cating a lack of tonic (background) G protein inhibition. To
elicit a putative G protein inhibition of LCav2a-5rbA channel
activity, we added 100 M GTPS to the patch pipette but
consistently failed to observe current activity upon cell rupture
in seven experiments. In one additional experiment, however,
current activity could be observed but was completely elimi-
nated within 2 min of cell rupture and could not be recovered
with application of prepulses. These data suggest the possibil-
ity that rapid dialysis of the cell with GTPS may have resulted
in an irreversible inhibition of LCav2a-5rbA activity. To exam-
ine this possibility, the very tip of the recording pipette was
filled with intracellular recording solution, and the rest of the
pipette was back-filled with GTPS-containing solution, thus
allowing us to slow the dialysis of the cell with GTPS. As
shown in Fig. 6A, this resulted in the appearance of inward
barium currents. However, unlike under control conditions,
where currents remained stable over a time course of 10–15
min (not shown), channel activity decayed rapidly, presumably
due to activation of G proteins in response to dialysis with
GTPS. The application of prepulses had only little effect on
current amplitude, indicating that membrane depolarization
was ineffective in reversing the GTPS-mediated inhibition.
For comparison, rat N-type calcium channels would under
these conditions display a 200–300% increase in peak current
amplitude in response to application of the prepulse (44).
This leaves two possibilities. First, as in mammalian Cav2.2
calcium channels, G subunits liberated by GTPS-induced
dissociation of the heterotrimeric G protein complex could per-
haps directly bind to the channel to inhibit channel opening. If so,
then binding would have to be unusually tight since prepulses
were ineffective in relieving the GTPS-mediated inhibition. As
seen in Fig. 6B, the LCav2a-5rbA channel and the rat Cav2.2
channel share a high degree of sequence homology in the first
putative G protein binding motif in the domain I-II linker (which
overlaps with the calcium channel  subunit interaction site,
alpha interaction domain sequence), whereas in the second pu-
tative G protein region identified in rat Cav2.1 and Cav2.2 chan-
nels (7, 15), there is little sequence similarity to the LCav2a
channel. It is, thus, conceivable that this results in a more stable
G protein-channel interaction that is resistant to membrane
depolarization.
Alternatively, it is possible that G subunits might be in-
capable of interacting with the LCav2a-5rbA channel. Instead,
FIG. 3. A, family of whole cell currents
recorded from the LCav2a-5rbA calcium
channel coexpressed with rat 1b and
2-1 subunits. The cell was held at 100
mV and depolarized to various test poten-
tials at 10-s intervals. B, ensemble of
whole cell current-voltage relations from
26 different experiments. In each case,
the holding potential was 100 mV. The
solid line reflects a fit as described under
“Experimental Procedures.” The parame-
ters obtained from the fit were as follows:
G  8.2 nanosiemens, S  6.39 mV,
Erev  63.3 mV, Va  8.5 mV. C, ensem-
ble of 14 steady state inactivation curves
obtained at a test potential of 20 mV. The
solid line is a fit with the Boltzmann rela-
tion. The parameters obtained from the fit
were as follows: Vh  39.9, S  8.04 mV.
D, voltage dependence of the time constant
of inactivation, , obtained at a holding
potential of 100 mV. The time constants
were obtained as described under “Experi-
mental Procedures.”















GTPS might trigger an intracellular signaling cascade that
could secondarily inhibit channel activity. A number of electro-
physiological studies in preparations of identified molluscan
neurons (including Lymnaea) could be consistent with the ex-
istence of such a mechanism (24). In Helisoma, Phe-Met-Arg-
Phe-NH2 triggers a PTX sensitive, Go-mediated inhibition of
calcium currents, which results in a depression of neurotrans-
mitter release (45) and inhibition of growth cone motility (46).
This effect could be mimicked by GTPS and was shown to be
irreversible (45, 46). Similar observations with Phe-Met-Arg-
Phe-NH2 inhibition of calcium currents have been reported for
neurons of Helix aspera, (47), Aplysia californica (48), and
Lymnaea (49). However, although there are some apparent
parallels to our observations with transiently expressed
LCav2a-5rbA channels, it remains to be determined whether
GTPS similarly affects native Lymnaea synaptic calcium cur-
rents. Nonetheless, it seems clear that the regulation of tran-
siently expressed LCav2a-5rbA calcium channels appears to be
fundamentally different from those of their mammalian coun-
terparts, but additional studies will need to be conducted to
pinpoint the precise signaling mechanism underlying the
unique regulation of this Cav2 calcium channel homolog.
Syntaxin1 Regulation of the LCav2a-5rbA Channel—We
have shown previously that unlike the rat N-type calcium
channel (1, 2, 26, 28, 32, 50), the LCav2a calcium channel is
incapable of directly interacting with syntaxin1 (21). This is
due primarily to the absence of the synaptic protein interaction
site in the LCav2a II-III linker region (Fig. 1B). Hence, one
would predict that the coexpression of syntaxin1, which in rat
N-type calcium channels results in a pronounced hyperpolar-
izing shift in half-inactivation potential (28, 32, 50), should not
affect LCav2a-5rbA channel gating. Rather than using rat
syntaxin1A or 1B, which we have characterized previously, we
used Lymnaea syntaxin1 (Lsytx1) for coexpression studies. To
demonstrate expression of Lsytx1 in tsA-201 cells, we first
generated a Western blot of tissue homogenated from mock-
and Lsytx1-transfected cells probed with an antibody to rat
syntaxin1 (Fig. 7A). We then coexpressed Lsytx1 with the rat
FIG. 4. A, whole cell recording from a LCav2a-5rbA (rat 1b  rat 2-1) calcium channel in 20 mM external barium and in 20 mM external
calcium at a test potential of 40 mV. The solid line indicates the base line. Note the reduction in peak current amplitude in external calcium. B,
example of a typical pair of current voltage relations obtained from the same cell in either 20 mM external barium (filled symbols) and 20 mM
external calcium (hollow symbols). Note the reduction in maximum slope conductance and the rightward shift in the peak of the current voltage
relation in external calcium. Inset, comparison of the maximum slope conductance values in barium and calcium in a total of six paired experiments
in form of a bar graph. C, the same whole cell currents as those shown in panel A but superimposed here to overlap at peak. Note the small degree
of speeding of the inactivation kinetics in external calcium. D, time constants for inactivation obtained at various test potentials in 20 mM barium
or in 20 mM calcium. In each of the six experiments included in the figure, time constants were measured under both conditions on the same cell.
The asterisks denote statistical significance to 0.05 (paired t test). E, alignment of the putative selectivity filter contributed by conserved residues
(especially conserved glutamic acid residue, underlined) in the pore region between segments 5 and 6 in homologous positions in the four
transmembrane domains of rat Cav2.1, rat Cav2.2, and LCav2a calcium channels.















FIG. 6. A, time course of current amplitude in response to intracellular dialysis with 100 M GTPS (n  7). Currents were elicited by
stepping from 100 mV to 20 mV, and every second test pulse was preceded by a depolarizing prepulse (PP) to 150 mV for 50 ms (open
symbols). For each experiment, all current amplitudes were normalized to the peak current value seen with the first test pulse. Note that
current rapidly decays in response to GTPS dialysis, but that this inhibition cannot be relieved by application of prepulses. B, sequence
alignment of the linker region between domains I and II of rat Cav2.1, rat Cav2.2, and LCav2a calcium channels. Note the high degree of
conservation in the first putative G/calcium channel  subunit binding site (alpha interaction domain), which contrasts with the sequence
divergence shown in the second G interaction site.
FIG. 5. A, representative time course of
block of LCav2a-5rbA calcium channels
by 3 M -conotoxin GVIA, 5 M nifedi-
pine, and 100 M cadmium. Note that
only cadmium appears to mediate signif-
icant inhibition. Inset, summary of the
blocking effects of GVIA, nifedipine, and
cadmium in the form of bar graphs. Cad-
mium always completely inhibited cur-
rent activity, and hence, no error bars are
evident. B, sequence alignment of the re-
gion from domain III S5 into the pore
linking IIIS5 to IIIS6 of rat Cav2.1, rat
Cav2.2, and the LCav2a calcium channels,
which is considered especially critical for
-conotoxin binding in Cav2.2 channels.















N-type calcium channel to determine whether Lsytx1 mediated
similar functional effects to those described for rat syntaxin1A,
that is, a hyperpolarizing shift in the midpoint of the steady
state inactivation curve, and a tonic G protein inhibition of the
channel triggered by syntaxin binding to the channel, which
can be assessed by application of strong depolarizing prepulse
(26, 32, 50). Interestingly, unlike rat syntaxin1A and 1B,
Lsytx1 did not affect the position of the steady state inactiva-
tion curve of the rat N-type channel (control, Vh  44.8  1.7
mV, n  7; Lsytx1, Vh  47  2.4 mV, n  10, see Fig. 7B)
despite being able to bind to its domain II-III linker region as
we showed recently (21). The lack of Lsytx1 expression on rat
N-type channel inactivation is, however, somewhat surprising
since Lsytx1 is highly homologous to both rat syntaxin1A and
-1B (see Fig. 7C), both of which affect N-type channel gating
(32). This result may, thus, provide novel clues about the syn-
taxin structural determinants that are required to affect N-
type channel gating. In the presence of Lsytx1, we did, however,
detect tonic G protein inhibition of the rat N-type channel (32 
7% current enhancement by the prepulse, n  10, not shown),
which differed significantly from background. Although this
effect was not nearly as large at that described by us previously
for rat syntaxin1A (80% enhancement after the prepulse; see
Ref. 32), this observation together with the Western blot shown
in Fig. 7A suggests that Lsytx1 was functionally expressed in
tsA-201 cells and is active on the N-type channel.
FIG. 7. A, Western blot stained with a syntaxin1 antibody illustrating Lymnaea syntaxin1 (Lsytx1) expression in Lsytx1-transfected tsA-201 cells
(35-kDa band) and in Lymnaea brain homogenate. Note the absence of signal in the control lane of the mock-transfected cells. B, comparison of
half-inactivation potentials obtained with LCav2a-5rbA or rat Cav2.2 (each coexpressed with rat 1b and 2-1 subunits) with or without
coexpression of Lsytx1 (and as indicated, the C terminus of the -adrenergic receptor kinase, -ARKct, which serves as a G sink; see Ref. 39).
Note that neither the rat N-type channel nor the LCav2a-5rbA channel undergoes a negative shift half-inactivation potential. Numbers in
parentheses indicate the numbers of experiments. C, sequence alignment of rat syntaxin1A, rat syntaxin1B and Lymnaea syntaxin1. Note the high
degree of homology among the three syntaxin isoforms.















We next examined the action of Lsytx1 on the functional
properties of the LCav2a-5rbA calcium channel. To eliminate
any syntaxin-mediated G protein inhibition that might inter-
fere with our ability to record from the channel, we also coex-
pressed the C-terminal fragment of the -adrenergic receptor
kinase (-ARKct), a known inhibitor of G-mediated signaling
events (26). Under these circumstances, the half-inactivation
potential of the channel was not significantly affected by the
presence of Lsytx1 (Fig. 7C), consistent with our previous re-
port showing that Lsytx1A is incapable of binding to the chan-
nel in vitro (21). These data suggest that the modulation of
presynaptic calcium channel gating by syntaxin1 is likely a
vertebrate specialization.
Potential Limitations of Our Study—In this study, the 5 end
of rat Cav2.1 was necessary to promote the expression of this
channel in mammalian cells. Without this modification, the
functional description of the invertebrate channel would not
have been possible, thus making use of a chimeric channel was
a necessary evil. Based on previous structure function studies
on mammalian calcium channels, many of the functional prop-
erties that we examined here (permeation, p loops (37, 38);
voltage-dependent inactivation, I-II linker and S6 segments
(51–56); calcium-sensitive inactivation, C terminus (57–60);
dihydropyridine sensitivity, IIS5, IIIS6, and IVS6 segments
(61, 62); conotoxin block, IIIS5-S6 region (27, 36); syntaxin
regulation, II-III linker (1, 2, 7, 11, 26, 28, 32, 50)) are unlikely
to be affected by the presence of the mammalian Cav2.1 N-
terminal sequence. However, this may not be so with regard to
G protein regulation of the channel, if it were to be mediated by
a direct action of G subunits on the channel. Although the
major G interaction sites on the mammalian Cav2 channels
are found in the domain I-II linker and the C-terminal regions
(15, 40, 63), the N terminus has been implicated in regulating
the functional effects of G protein  subunits on N-type chan-
nel activity (64). Thus, whereas mammalian Cav2.1 channels
are typically only weakly regulated by direct action of G (13,
39, 41), we cannot rule out the possibility that the presence of
the Cav2.1 N terminus could enhance a putative direct G
modulation of LCav2a. However, as we discussed above, in light
of previous literature, it appears more likely that the GTPS-
mediated inhibition is due to an indirect regulation by one or
more second messengers. Future experiments will attempt to
delineate the exact messenger pathway involved and whether
the observed effects are affected by the presence of the Cav2.1
N terminus.
Novel Perspectives from Our Studies—Here we provide for
the first time a functional description of an expressed inverte-
brate synaptic Cav2 calcium channel in a mammalian cell line.
First, we show here that properties of mammalian Cav2
channels cannot be universally applied to invertebrates, since
toxin sensitivity and regulation of the channels by syntaxin1
appear to be unique to vertebrate channels. At the molecular
level, such differences may in part reflect modifications or
adaptations in the calcium-dependent neurotransmitter re-
lease process in either invertebrates or vertebrates.
Second, despite structural divergences, many of the charac-
teristic biophysical features of mammalian P/Q- and N-type
channels are found in the LCav2a-5rbA channels. Selective
permeability to ions (barium and calcium) and responsiveness
to changes in membrane voltage, including the rate and thresh-
old of activation and inactivation, are remarkably similar, sug-
gesting that the fundamental biophysical characters responsi-
ble for calcium- and voltage-dependent synaptic transmission
are conserved at the level of the calcium channel. This similar-
ity is shared at a biophysical level of invertebrate synaptic
transmission where kinetic features of calcium-dependent neu-
rotransmitter release are comparable with mammalian ones.
Third, as we reported previously, the invertebrate channel
LCav2a lacks an equivalent for the mammalian synaptic pro-
tein interaction (synprint) site in the II-III linker, enabling it to
bind synaptic proteins such as Lymnaea syntaxin1 or even
mammalian syntaxin1A. Conversely, there is a reverse com-
patibility from mammals to invertebrates, where mammalian
synprint binds with high affinity to invertebrate synaptic pro-
teins, including syntaxin1, SNAP-25, and synaptotagmin1 (21).
A functional consequence is that application of a synprint pep-
tide to an invertebrate synapse blocks synaptic transmission as
has been reported in mammals (21). To our surprise however,
the invertebrate syntaxin (Lsytx1) does not appear to be func-
tionally compatible with mammalian Cav2 channels. Even
though Lsytx1 is strikingly homologous to both mammalian
syntaxin1A and syntaxin1B (see Fig. 7C) and capable of phys-
ically binding to Cav2.2 (21), we did not observe an Lsytx1-
induced reduction in Cav2.2 channel availability. This brings a
unique perspective to the relationship between synaptic cal-
cium channels and synaptic proteins, suggesting that Cav2
channels and syntaxin1 may have coevolved to allow for syn-
taxin-mediated regulation of Cav2 channel activity. Indeed,
minor residue changes in syntaxin1 and more profound adap-
tations such as the insertion of a 250–300-amino acid syn-
print domain into vertebrate Cav2 calcium channels appear
required to allow a functional regulation of mammalian Cav2
channels by syntaxin1. The lack of this interaction in inverte-
brates may perhaps provide an opportunity to reconstitute
functional interactions between synaptic calcium channels and
synaptic proteins and investigate their consequences on syn-
aptic release, thus providing novel insights into the intricacies
of synaptic transmission.
Finally, identified synapses between Lymnaea neurons are
highly amenable for analysis using molecular and electrophysi-
ological approaches and optical imaging (21, 65–67). A com-
bined approach using in vitro expression and hypothesis test-
ing in native invertebrate neurons may, thus, permit us to
dissect the interplay between presynaptic calcium channels,
second messenger systems, and synaptic proteins.
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